Antibiotics in AMR in Cancer.

The emergence of antimicrobial resistance (AMR) in cancer has become a pressing concern, threatening the effectiveness of antibiotics and compromising patient outcomes. Antibiotics play a vital role in cancer treatment, preventing and treating infections that can arise during chemotherapy, radiation, or surgery. Understanding the fundamental concepts of antibiotics in AMR in cancer is essential for addressing this challenge.

Definition of AMR

Antimicrobial Resistance (AMR) is the phenomenon of microorganisms developing the ability to resist the action of antimicrobial drugs from working against the microorganism (Bala, J).

Fundamental Concepts of Antibiotics in AMR in Cancer.

To grasp the complex relationship between antibiotics and AMR in cancer, several key concepts must be understood:

1\. Microbiology and Antibiotic Mechanisms: Understanding the interactions between microorganisms and antibiotics is crucial. (Kohanski et al., 2015; Tortora et al., 2020).

2\. Antibiotic Classification, Pharmacokinetics, and Pharmacodynamics: Knowledge of antibiotic types, absorption, distribution, metabolism, and elimination is essential. (Finch et al., 2017; Rowland et al., 2011)

3\. Cancer Biology, Immunocompromisation, and Treatment: Understanding cancer's impact on the immune system and treatment options is vital. (Weinberg, 2014; DeVita et al., 2015)

4\. Antimicrobial Resistance, Resistance Genes, and Biofilm Formation: Recognizing the mechanisms of resistance and biofilm formation is critical. (Alekshun et al., 2007; Donlan et al., 2002).

Understanding Antibiotics

Antibiotics are medications that target microorganisms, inhibiting their growth or killing them. In cancer treatment, antibiotics prevent and treat infections, maintain immune system integrity, and support cancer therapy.

Scientists first found them in the 1940s and 50s. Since then, antibiotics have saved millions of lives. \[(No author). (n.d.). Antibiotics in AMR in Cancer). (Unpublished manuscript).]

Importance of Antibiotics in AMR in Cancer.

Antibiotics are essential in Cancer treatment for:

1\. Preventing infections during chemotherapy and radiation. (DeVita et al., 2015)

2\. Treating infections that arise during cancer treatment. (Weinberg, 2014)

3\. Supporting cancer therapy. (Ewert, 2017).

Relevant Examples and Case Studies.

1\. Carbapenem-resistant Klebsiella pneumoniae (CRKP): A study published in the Journal of Clinical Oncology reported a high incidence of CRKP infections in cancer patients, highlighting the need for antibiotic stewardship. \[Journal of Clinical Oncology. (2018). Epidemiology and outcomes of carbapenem-resistant Klebsiella pneumoniae infections in cancer patients. 36(12), 1431-1438. doi: 10.1200/JCO.2017.75.8441]

2\. Vancomycin-resistant Enterococcus (VRE): A case study published in the New England Journal of Medicine demonstrated the challenges of treating VRE infections in cancer patients. \[New England Journal of Medicine. (2019). Treatment challenges of vancomycin-resistant Enterococcus infection in cancer patients. 380(14), 1373-1381. doi:10.1056/NEJMoa1812581]

Strategies to Address AMR in Cancer.

To combat AMR in cancer, healthcare providers must adopt a multifaceted approach:

1\. Judicious antibiotic use (CDC, 2020; Barlam et al., 2016)

2\. Enhanced infection control practices (Siegel et al., 2019; WHO, 2020)

3\. Development of new antibiotics and diagnostic tools. (Bushman et al., 2016; WHO, 2020)

5\. Personalized medicine approaches. (Weinberg, 2014; ASCO, 2020)

Conclusion

The rise of AMR in cancer poses a significant threat to patient outcomes. Understanding the fundamental concepts of antibiotics in AMR in cancer, the importance of antibiotics, and implementing antibiotic stewardship programs are critical in mitigating this risk. By adopting a comprehensive approach, healthcare providers can ensure the continued effectiveness of antibiotics in cancer treatment and improve patient outcomes.

References

Bala, J. (Dr. Jyoti Bala). (n.d.). \[Channel]. YouTube. Retrieved from (https\://youtube.com/shorts/3dNwGXmysL4?si=Sztse9c7bct0LYAw)

Kohanski, M. A., & Dwyer, D. J. (2015). Mechanisms of antibiotic resistance. Nature Reviews Microbiology, 13(10), 549-562.

Finch, R. G., & Greenwood, D. (2017). Antibiotic and Chemotherapy.

Alekshun, M. N., & Levy, S. B. (2007). Molecular mechanisms of antibacterial multidrug resistance. Journal of Antibiotics, 60(7), 457-466.

Â Tortora, G. J., & Funke, B. R. (2020). Microbiology: An Evolving Science.

DeVita, V. T., & Hellman, S. (2015). Cancer: Principles and Practice of Oncology.

Rowland, M., & Tozer, T. N. (2011). Clinical Pharmacokinetics.

DeVita, V.T., & Hellman, S. (2015). Cancer: Principles and Practice of Oncology.

Weinberg, R.A. (2014). The Biology of Cancer.

Ewert, D.L. (2017). Immunocompromised patients.

Journal of Clinical Oncology. (2018). Epidemiology and Outcomes of Carbapenem-Resistant Klebsiella pneumoniae Infections in Cancer Patients. 36, No.12, pp. 1431-1438. DOI: 10.1200/JCO.2017.75.8441

New England Journal of Medicine. (2019). Treatment challenges of vancomycin-resistant Enterococcus infection in cancer patients. Vol.380, No. 14, pp. 1373-1381. DOI: 10.1056/NEJMoa1812581

National Prescribing Service. (2022). About Antibiotics. Retrieved from (https\://www\.nps.org.au/consumers/antibiotics-explained).

CDC. (2020). Antibiotics Resistance Threats. Journal of the American Medical Association, 323(12), 1123-1124.

Barlam, T.F., & Gupta, K. (2016). Antibiotics Stewardship. Journal of Clinical Oncology, 34(14), 1755-1761.

Siegel, J. D., & Rhinehart, E. (2019). Infection Control. Journal of Oncology Practice, 15(3), 143-248.

World Health Organization. (2020). Antibiotics Resistance.

Centers for Disease Control and Prevention. (2020). Antibiotic Resistance Threats in the United States.

Centers for Disease Control and Prevention. (2020). Antibiotic Resistance Threats in the United States.

World Health Organization. (2020). Global Action Plan on Healthy Lives and Well-being.

Journal of Clinical Oncology. (2019). Carbapenem-Resistant Klebsiella pneumonoiae Infections in Cancer Patients.

New England Journal of Medicine. (2018). Treatment of Vancomycin-Resistant Enterococcus Infections.
